[{"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96162", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0216-2025", "product_description": "Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01, Manufactured for Glenmark Pharmaceuticals, NJ.", "product_quantity": "", "reason_for_recall": "CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20250122", "center_classification_date": "20250203", "report_date": "20250212", "code_info": "Lot numbers: a) 17230658, Exp.: 02/2025; 17230814,17230822, Exp.: 03/2025; 17231004,17231009,17231022, Exp.: 04/2025; 17231393,17231392, Exp.: 05/2025; 17231538, 17231541,17231542, Exp.: 06/2025; 17231710,17231718,17231721,17231722,17231730, Exp': 07/2025; 17232169, Exp.: 09/2025; 17232253, Exp.: 10/2025; 17240220,17240240, Exp.: 01/2026; 17240459, Exp.: 02/2026   b) 17230814, Exp.: 03/2025; 17231392, Exp.:05/2025; 17232260, Exp.: 10/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Maryland Heights", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078098"], "brand_name": ["TECHNETIUM TC 99M SESTAMIBI"], "generic_name": ["TECHNETIUM TC 99M SESTAMIBI"], "manufacturer_name": ["Curium US LLC"], "product_ndc": ["69945-092"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE"], "spl_id": ["4b00526c-6250-49d7-ba34-459ef89c8f43"], "spl_set_id": ["4110d0f4-3bcf-4688-a39f-42a81064c796"], "package_ndc": ["69945-092-20", "69945-092-40"], "is_original_packager": [true], "unii": ["N6OU7HJ70P"]}, "product_type": "Drugs", "event_id": "95839", "recalling_firm": "Curium US, LLC", "address_1": "2703 Wagner Pl", "address_2": "", "postal_code": "63043-3421", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Canada.", "recall_number": "D-0164-2025", "product_description": "Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate -  0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg.  The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only,  Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40", "product_quantity": "5,160 vials (172 kits 30 vials/kit)", "reason_for_recall": "Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product", "recall_initiation_date": "20241126", "center_classification_date": "20241226", "termination_date": "20251010", "report_date": "20250101", "code_info": "Lot 092-24006, Catalog # N092D0, Exp 06/15/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96764", "recalling_firm": "RemedyRePack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Within U.S - PA, VA, FL.", "recall_number": "D-0411-2025", "product_description": "Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02", "product_quantity": "23 bottles/30 count- 690 capsules", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250422", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216379"], "brand_name": ["TIROFIBAN"], "generic_name": ["TIROFIBAN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-429", "55150-430"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TIROFIBAN HYDROCHLORIDE"], "rxcui": ["1737466", "1737471"], "spl_id": ["1751523a-e22e-4faf-bdb1-c850afe2fd36"], "spl_set_id": ["d554acff-22e9-4f28-b826-ee1b91daa2df"], "package_ndc": ["55150-429-01", "55150-430-01"], "is_original_packager": [true], "upc": ["0355150430017", "0355150429011"], "unii": ["6H925F8O5J"]}, "product_type": "Drugs", "event_id": "96718", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0390-2025", "product_description": "Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01", "product_quantity": "N/A", "reason_for_recall": "Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.", "recall_initiation_date": "20250421", "center_classification_date": "20250425", "report_date": "20250507", "code_info": "Lot# : 3TF24001, Exp 3/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0263-2025", "product_description": "Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.", "product_quantity": "5.1 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HACUC0010722, exp. date Jun-2025 HACUC0010123, exp. date Dec-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205932"], "brand_name": ["PITAVASTATIN"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["AvKARE"], "product_ndc": ["42291-905", "42291-906", "42291-907"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861648", "861652"], "spl_id": ["0f1207f0-5d7c-5aa6-e063-6394a90ab854"], "spl_set_id": ["0f11ee80-871e-4f13-e063-6394a90af19d"], "package_ndc": ["42291-906-90", "42291-907-90", "42291-905-90"], "original_packager_product_ndc": ["0480-3632", "0480-3633", "0480-3631"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "97160", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0528-2025", "product_description": "Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478.  NDC: 42291-905-90", "product_quantity": "1,560 bottles", "reason_for_recall": "Failed Impurity/Degradation Specifications", "recall_initiation_date": "20250626", "center_classification_date": "20250716", "report_date": "20250709", "code_info": "Lot, expiry:  Lot 46208, exp 10/31/2025; Lot 47738, exp 09/30/2026; Lot 46943, exp 05/31/2026;", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0156-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05", "product_quantity": "13,678 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT3023030A Exp 2/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["318417ff-d599-47b8-8181-89c3bb3b2e8d"], "spl_set_id": ["47a0313f-36df-4fa6-a828-c9e1946ba9b0"], "package_ndc": ["0264-7800-09"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "97433", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "N/A", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0628-2025", "product_description": "0.9% Sodium Chloride Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7800-09", "product_quantity": "47,148 containers", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20250818", "center_classification_date": "20250910", "report_date": "20250910", "code_info": "Lot #: V3K770, Exp 1/31/2026"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0562-2025", "product_description": "Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "194 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Completed", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96245", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0246-2025", "product_description": "Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30", "product_quantity": "4944 cartons", "reason_for_recall": "Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.", "recall_initiation_date": "20250206", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot # 193109; Exp. 07/31/2026"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217656"], "brand_name": ["ICOSAPENT ETHYL"], "generic_name": ["ICOSAPENT ETHYL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1592", "70710-1738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ICOSAPENT ETHYL"], "rxcui": ["1304979", "1811180"], "spl_id": ["b292c3ea-8ce0-471f-8c44-57d1c4df9bf5"], "spl_set_id": ["5910742b-c5e6-4029-9a19-97669e3808bc"], "package_ndc": ["70710-1738-4", "70710-1592-7"], "is_original_packager": [true], "upc": ["0370710159276"], "unii": ["6GC8A4PAYH"]}, "product_type": "Drugs", "event_id": "96964", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL, PA, & MS", "recall_number": "D-0497-2025", "product_description": "Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.", "product_quantity": "11,616 bottles", "reason_for_recall": "Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.", "recall_initiation_date": "20250530", "center_classification_date": "20250630", "report_date": "20250618", "code_info": "Lot #s: B237040, B237041, Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0439-2025", "product_description": "Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 1.5 OZ (43 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-04", "product_quantity": "150,768 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0004, Exp Date: 05/31/2026; B0060, Exp Date: 07/31/2026; Lot B0067, B0071, B0072, Exp Date: 08/31/2026; Lot B0107, B0108, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216595"], "brand_name": ["PROCHLORPERAZINE MALEATE"], "generic_name": ["PROCHLORPERAZINE MALEATE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-889", "68462-890", "68462-947"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROCHLORPERAZINE MALEATE"], "rxcui": ["198365", "312635"], "spl_id": ["c56758e4-6b1c-4ad1-a342-452dfd4d5679"], "spl_set_id": ["9c806152-70d0-43eb-b183-b51b12b82b31"], "package_ndc": ["68462-889-01", "68462-889-10", "68462-890-01", "68462-890-10", "68462-947-01", "68462-947-10"], "is_original_packager": [true], "upc": ["0368462889015", "0368462947012"], "unii": ["I1T8O1JTL6"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0338-2025", "product_description": "Prochlorperazine Maleate Tablets, 10mg, 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-890-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240254, exp. date Jan-26 17240257, exp. date Jan-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010", "202517231315"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96162", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0215-2025", "product_description": "Carvedilol Tablets, USP, 25 mg, Rx only, a)500 Tablets, NDC 68462-165-05; b) 100 Tablets, NDC 68462-165-01, Manufactured for Glenmark Pharmaceuticals, NJ.", "product_quantity": "", "reason_for_recall": "CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20250122", "center_classification_date": "20250203", "report_date": "20250212", "code_info": "Lot numbers: a) 17230500, 17230509,17230526,17230546,17230551,17230603,17230628, 17230642,17230645,17230681, Exp.:02/2025; 17230829,17230832,17230854, 17230864,17230874,17230876,17230889,17230894, Exp.: 03/2025; 17230960, 17230964,17230976,17230981,17230985,17231161,17231171, Exp.: 04/2025 17231315,17231318,17231332,17231333,17231365, Exp.: 05/2025; 17231539, 17231563, Exp.: 06/2025; 17231653,17231662,17231663,17231680,17231691, 17231781,17231782,17231789, Exp.: 07/2025;17231838,17231880, Exp.: 08/2025; 17232144,17232147,17232151, Exp.: 09/2025; 17232369,17232370,17232408,17232409, 17232416,17232504,17232522,17232531,17232538,17232543, Exp.: 11/2025; 17240377,17240385,17240415,17240422,17240430,17240510, Exp.: 02/2026.  b) 17230551, 17240377, Exp.:02/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "51754-5001-1"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "96481", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0303-2025", "product_description": "8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4", "product_quantity": "103,950 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250307", "center_classification_date": "20250327", "report_date": "20250402", "code_info": "Lots: 10006417 and 10006418, Exp. 11/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205994"], "brand_name": ["SAXAGLIPTIN"], "generic_name": ["SAXAGLIPTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-726", "68462-727"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SAXAGLIPTIN HYDROCHLORIDE"], "rxcui": ["858036", "858042"], "spl_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "spl_set_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "package_ndc": ["68462-726-30", "68462-726-90", "68462-726-05", "68462-727-30", "68462-727-90", "68462-727-05", "68462-727-14"], "is_original_packager": [true], "upc": ["0368462726907"], "unii": ["Z8J84YIX6L"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0345-2025", "product_description": "Saxagliptin Tablets, USP, 2.5mg, a). 30-count bottle (NDC# 68462-726-30), b).90-count bottle(NDC# 68462-726-90), Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "30-Count Bottle Lots:   17241788, exp. date Sep-26 17241821, exp. date Sep-26 17241822, exp. date Sep-26   90-Count Bottle Lot:  17241822, exp. date Sept 26"}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0262-2025", "product_description": "Finasteride  NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.", "product_quantity": "120.0 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Numbers: HAFSC0040923, exp. date Aug-2027 HAFSC0050923, exp. date Aug-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Santa Fe Springs", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97175", "recalling_firm": "Central Admixture Pharmacy Services, Inc (CAPS)  Los Angeles", "address_1": "13128 Imperial Hwy", "address_2": "N/A", "postal_code": "90670-4817", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA", "recall_number": "D-0530-2025", "product_description": "PERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only, Single Dose Injection, a) 1440 mL bag, b) 1700 mL bag, Central Admixture Pharmacy Services, Inc, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90870.", "product_quantity": "2 bags", "reason_for_recall": "Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.", "recall_initiation_date": "20250701", "center_classification_date": "20250716", "report_date": "20250723", "code_info": "Lot: a) 11-4785290-0-1, BUD: 6/19/2025 @ 11:32 pm; b) 11-4785217-0-1, BUD: 6/19/2025 @ 10:25 pm."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0235-2025", "product_description": "Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-269-30.", "product_quantity": "80,160 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234630, Exp.: 10/2025; 19240528, 19240529, Exp.: 1/2026."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210965"], "brand_name": ["PROGESTERONE"], "generic_name": ["PROGESTERONE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-306"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PROGESTERONE"], "rxcui": ["312644"], "spl_id": ["44ca9ab1-7336-4914-b059-79559747ac39"], "spl_set_id": ["7d19df3b-94ed-4681-beae-9caaf137d014"], "package_ndc": ["55150-306-10"], "is_original_packager": [true], "nui": ["M0017672", "N0000175601"], "pharm_class_cs": ["Progesterone [CS]"], "pharm_class_epc": ["Progesterone [EPC]"], "unii": ["4G7DS2Q64Y"]}, "product_type": "Drugs", "event_id": "96073", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0186-2025", "product_description": "Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520  NDC # 55150-306-10", "product_quantity": "17,300 10-mL vials", "reason_for_recall": "Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.", "recall_initiation_date": "20241227", "center_classification_date": "20250107", "report_date": "20250115", "code_info": "Batch # 1PR24010, Expiry: 02/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0555-2025", "product_description": "Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "170 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213212"], "brand_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "generic_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-689", "16571-690", "16571-691", "16571-692", "16571-693", "16571-694"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBIDOPA", "ENTACAPONE", "LEVODOPA"], "rxcui": ["403850", "403851", "403852", "730988", "810083", "810090"], "spl_id": ["bb341ca1-04d3-4a71-b79d-824653aa58a3"], "spl_set_id": ["2f8e82d7-6baf-456a-b8c3-4fda6e317902"], "package_ndc": ["16571-689-01", "16571-690-01", "16571-691-01", "16571-692-01", "16571-693-01", "16571-694-01"], "is_original_packager": [true], "upc": ["0316571689019", "0316571692019", "0316571694013", "0316571690015", "0316571691012", "0316571693016"], "nui": ["N0000175754", "N0000175755", "N0000175756", "N0000175757", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Catechol-O-Methyltransferase Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]", "Catechol O-Methyltransferase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "4975G9NM6T", "46627O600J"]}, "product_type": "Drugs", "event_id": "97768", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0029-2026", "product_description": "Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01", "product_quantity": "2,064 100-count bottles", "reason_for_recall": "Product mix up:  complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).", "recall_initiation_date": "20251007", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot # CS25070, exp. date 03/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0239-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-756-01.", "product_quantity": "119,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233228, 19233227, Exp.: 7/2025; 19233757, Exp.: 8/2025; 19234229, Exp.: 9/2025; 19235090, Exp.: 11/2025; 19241471, Exp.:3/2026; 19242180, Exp.: 5/2026."}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0440-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 2.75 OZ (78g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-05", "product_quantity": "160,848 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0032, B0047, B0048, B0055, B0056, Exp Date: 07/31/2026; B0102, B0103, B0104, B0105, B0106, B0107, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203269"], "brand_name": ["RIZATRIPTAN BENZOATE"], "generic_name": ["RIZATRIPTAN BENZOATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-261", "67877-262"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIZATRIPTAN BENZOATE"], "rxcui": ["312840", "314209"], "spl_id": ["9fd3ccaa-ae93-475b-9591-5c4af70f51c5"], "spl_set_id": ["07e66554-bc85-4853-9f40-1249617630a9"], "package_ndc": ["67877-261-30", "67877-261-01", "67877-261-05", "67877-261-18", "67877-261-25", "67877-262-30", "67877-262-01", "67877-262-05", "67877-262-18", "67877-262-25"], "is_original_packager": [true], "upc": ["0367877261300"], "unii": ["WR978S7QHH"]}, "product_type": "Drugs", "event_id": "96770", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0534-2025", "product_description": "Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-262-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250709", "center_classification_date": "20250717", "report_date": "20250723", "code_info": "Lot 22143653, 22143675, Exp Date: July 2025; Lot 22144528, Exp Date: September 2025; Lot 22144977, Exp Date: November 2025; Lot 23140257, Exp Date: December 2025; Lot 23140999, Exp Date: Feb. 2026; Lot 23141900, 23142118, 23142120, 23142123, Exp Date: May 2026; Lot 23144563, 23144565, Exp Date: November 2026; Lot 24142623, Exp Date: May 2027;  Lot 24142624, 24142626, 24143469, Exp Date: Jun. 2027."}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0518-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-15", "product_quantity": "82,159 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300325, Exp Date: 01/31/2026; Lot #D2400536, Exp Date: 02/28/2026"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M017"], "brand_name": ["DERMASARRA"], "generic_name": ["OTC TOPICAL ANALGESIC DRUG PRODUCTS"], "manufacturer_name": ["DERMARITE INDUSTRIES, LLC"], "product_ndc": ["61924-189"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CAMPHOR (NATURAL)"], "rxcui": ["2059052"], "spl_id": ["28880b59-b008-e343-e063-6394a90a1844"], "spl_set_id": ["1fad8650-8bd6-4711-9121-b9f6ff8bdf6b"], "package_ndc": ["61924-189-08"], "is_original_packager": [true], "upc": ["0714196188083"], "unii": ["N20HL7Q941"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0611-2025", "product_description": "DermaSarra, External Analgesic, (Camphor 0.5%)  222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08", "product_quantity": "249 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot #: 40187.2, Exp. Date 2/2026"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA077829"], "brand_name": ["CETIRIZINE HYDROCHLORIDE"], "generic_name": ["CETIRIZINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-402"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CETIRIZINE HYDROCHLORIDE"], "rxcui": ["1014678"], "spl_id": ["76ebe5e7-afda-45c3-bf06-07e37827a07a"], "spl_set_id": ["5481ccb3-b311-4b25-b923-4fe8522ea92b"], "package_ndc": ["16571-402-10", "16571-402-50"], "is_original_packager": [true], "unii": ["64O047KTOA"]}, "product_type": "Drugs", "event_id": "97573", "recalling_firm": "JB Chemicals and Pharmaceuticals Ltd", "address_1": "Neelam Centre A Wing A B Wing", "address_2": "4th Floor; Hind Cycle Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0032-2026", "product_description": "Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.", "product_quantity": "9936 bottles", "reason_for_recall": "Tablet/Capsules Imprinted with Wrong ID", "recall_initiation_date": "20250912", "center_classification_date": "20251017", "report_date": "20251029", "code_info": "Lot # PY925014A; Exp. 1/31/2028", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0434-2025", "product_description": "Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 1.5 OZ (43 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-04", "product_quantity": "216,720 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0013, Exp Date: 05/31/2026; Lot B0018, Exp Date: 06/30/2026; Lot B0053, B0054, Exp Date: 07/31/2026; Lot B0090, B0091, B0092, B0093, B0094, B0095, B0096, B0097, B0098, B0099, B0100, B0101, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212294"], "brand_name": ["TAVABOROLE"], "generic_name": ["TAVABOROLE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TAVABOROLE"], "rxcui": ["1543177"], "spl_id": ["266f7bbc-b540-4681-8144-cbb823f34f0e"], "spl_set_id": ["c13610c8-c57a-4519-b37d-eb4fbdcec398"], "package_ndc": ["72578-102-04"], "is_original_packager": [true], "nui": ["N0000191279", "N0000000150", "M0002832"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "pharm_class_cs": ["Boron Compounds [CS]"], "unii": ["K124A4EUQ3"]}, "product_type": "Drugs", "event_id": "97756", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0016-2026", "product_description": "Tavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar, Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-102-04.", "product_quantity": "13080 bottles", "reason_for_recall": "Discoloration - Expansion of RES #97424", "recall_initiation_date": "20251006", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot#: T400819, T400820, Exp 4/30/26; T401969, Exp 9/30/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0244-2025", "product_description": "Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-761-01.", "product_quantity": "58,368 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233270, 19233278, 19233285, Exp.: 7/2025; 19233806, Exp.: 8/2025; 19240954, Exp.: 2/2026; 19241854, Exp.: 4/2026."}, {"status": "Ongoing", "city": "Newton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96052", "recalling_firm": "First Aid Beauty Ltd", "address_1": "70 Bridge St", "address_2": "Suite 203", "postal_code": "02458-1140", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2025", "product_description": "First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR. BY: First Aid Beauty LTD, Newton, MA, 02458, UPC 8 15517 02955 6", "product_quantity": "2756 jars", "reason_for_recall": "CGMP Deviations; product intended for quarantine was inadvertently distributed", "recall_initiation_date": "20241223", "center_classification_date": "20250121", "report_date": "20250129", "code_info": "Lots 24D44, Exp 4/10/2026 & 24D45, 4/11/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Yunlin County", "state": "", "country": "Taiwan", "classification": "Class III", "openfda": {"application_number": ["ANDA205932"], "brand_name": ["PITAVASTATIN"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "product_ndc": ["0480-3631", "0480-3632", "0480-3633"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861648", "861652"], "spl_id": ["191b4856-1662-a7b8-e063-6394a90a2c56"], "spl_set_id": ["fac09182-dcf2-1770-e053-6394a90af50c"], "package_ndc": ["0480-3632-98", "0480-3633-98", "0480-3631-98"], "is_original_packager": [true], "upc": ["0304803633985", "0304803631981", "0304803632988"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "97076", "recalling_firm": "Orient Pharma Co., Ltd. Yunlin Plant", "address_1": "No. 8 Kehu 1st Rd.", "address_2": "Huwei Township", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0527-2025", "product_description": "Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3631-98.", "product_quantity": "20618 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20250611", "center_classification_date": "20250716", "report_date": "20250709", "code_info": "P051001, P051002, & P051003, Exp Date 07/2025; P051005, Exp Date 10/2025; P051006, Exp Date 10/2025; P051007, Exp Date 01/2026; P051010, Exp Date 07/2026; P051011 & P051012, Exp Date 09/2026; P051013, P051014 and P051015, Exp Date 01/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0670-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-030-01", "product_quantity": "11,895 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "lot#: GPC250159A, Exp Date: 06-22-2027", "more_code_info": ""}, {"status": "Completed", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96306", "recalling_firm": "Turbare Manufacturing", "address_1": "925 Jeanette Dr", "address_2": "N/A", "postal_code": "72032-6651", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0248-2025", "product_description": "Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.", "product_quantity": "1,147 syringes", "reason_for_recall": "Lack of Assurance of Sterility: due to a quality control process deviation. During an internal quality assurance review, an Acceptable Quality Limit (AQL) inspection was not conducted on a statistically sound number of samples. This may result in the inability to assure that the impacted products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess and may lead to products of unacceptable quality.", "recall_initiation_date": "20250218", "center_classification_date": "20250221", "report_date": "20250305", "code_info": "Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025)."}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0500-2025", "product_description": "KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.", "product_quantity": "23,200 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206055"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-848", "68382-849"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["bc31956a-671b-4ca3-b9dd-1fdb03003cae"], "spl_set_id": ["190a4c5b-1547-45d7-b00b-10da4131e2e2"], "package_ndc": ["68382-848-94", "68382-849-94"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "96860", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide -in the USA", "recall_number": "D-0443-2025", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534,  NDC 68382-848-94", "product_quantity": "22,152 30 sachets/carton", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.", "recall_initiation_date": "20250513", "center_classification_date": "20250520", "report_date": "20250528", "code_info": "Lot #:M402147, Exp 10/2025; M311637, Exp 07/2025; M402495, Exp 02/2026; M407997, Exp 05/2026; M502246, Exp11/2026."}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96707", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0387-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10", "product_quantity": "16,473 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250414", "center_classification_date": "20250422", "report_date": "20250430", "code_info": "Lot #  240987C, exp. date 04/2027 241014C, exp. date 04/2027"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210742"], "brand_name": ["CHLORTHALIDONE"], "generic_name": ["CHLORTHALIDONE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-167"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORTHALIDONE"], "rxcui": ["197499"], "spl_id": ["df21e622-654c-2eab-e053-2995a90a5f1c"], "spl_set_id": ["972b801e-c4f2-4bd6-e053-2a95a90a53bb"], "package_ndc": ["50268-167-11", "50268-167-15"], "original_packager_product_ndc": ["43598-719"], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "96866", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0461-2025", "product_description": "Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15", "product_quantity": "962 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250509", "center_classification_date": "20250609", "report_date": "20250618", "code_info": "Lot # 47947, Exp 05/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0343-2025", "product_description": "Lacosamide Tablets 150mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-680-60.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241125, exp. date Jun-26 17242202, exp. date  Nov-26 17242204, exp. date Dec-26"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0431-2025", "product_description": "Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, Net Wt 0.6 OZ (17 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-02", "product_quantity": "391,680 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0009, B0017, Exp Date: 05/31/2026; Lot B0018, B0019, B0036, B0037, B0038, Exp Date: 06/30/2026; Lot B0049, Exp Date: 07/31/2026; B0063, Exp Date: 08/31/2026"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0024-2026", "product_description": "Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot #: 25156673A, Expiry: 02FEB2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210921"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7216"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "spl_id": ["9d5dc98f-9e9a-4303-8f20-446e84da3fcf"], "spl_set_id": ["a9d68a40-75e3-4c5c-b5d7-1d6160527fa7"], "package_ndc": ["0904-7216-61"], "original_packager_product_ndc": ["65862-987"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96201", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0221-2025", "product_description": "Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520.  Made in India.  Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152.  NDC: 0904-7216-61", "product_quantity": "6997 cartons", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20250130", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot# T05224; Exp. 02/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96636", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0368-2025", "product_description": "Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial,  Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for BluePoint Laboratories, NDC 68001-581-41.", "product_quantity": "14,189 vials", "reason_for_recall": "Lack of assurance of sterility. Bacterial contamination detected in some media fill units", "recall_initiation_date": "20250402", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "A240482A, EXP 08/31/2026"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["OPTIMV ANTI-ITCH"], "generic_name": ["BENZOCAINE, RESORCINOL"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-300"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE", "RESORCINOL"], "rxcui": ["637518"], "spl_id": ["2734db1a-7a67-9504-e063-6394a90a274d"], "spl_set_id": ["e064940f-83d7-85b6-e053-2995a90aec92"], "package_ndc": ["55758-300-07", "55758-300-01"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5", "YUL4LO94HK"], "upc": ["859424004206"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0427-2025", "product_description": "Optim V, Anti-Itch Cream, Benzocaine 20% & Resorcinol 3% - External analgesic, Net Wt. Peso Neto 1 oz (28g) Tube, Distributed by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-300-01, UPC 8 59424 00420 6.", "product_quantity": "6,372 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP24A, Exp: 09/30/2026"}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96707", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0388-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, a.) 90-count bottles (NDC# 51991-747-90), b.) 1000-count bottles (NDC 51991-747-10), Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L. Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922", "product_quantity": "343,344 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250414", "center_classification_date": "20250422", "report_date": "20250430", "code_info": "Lot #  230201C, exp. date 01/2026 230471C, exp. date 01/2026 230288C, exp. date 01/2026"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0155-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04", "product_quantity": "21,262 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot DT3023029A Exp 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211817"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-276", "55150-277", "55150-278"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["b622f795-00fa-48e3-8e4d-679c2ce28c6c"], "spl_set_id": ["f901e2b2-f143-4237-8e95-0d134585490b"], "package_ndc": ["55150-276-01", "55150-277-01", "55150-278-01"], "is_original_packager": [true], "upc": ["0355150276011", "0355150278015", "0355150277018"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "96680", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0363-2025", "product_description": "Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial,  Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01", "product_quantity": "36,816 vials", "reason_for_recall": "cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.", "recall_initiation_date": "20250410", "center_classification_date": "20250414", "report_date": "20250423", "code_info": "Lot #: 1TC24075A, Exp 11/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Berkeley Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Quallent Pharmaceuticals Health, LLC"], "product_ndc": ["82009-029", "82009-030", "82009-032", "82009-031"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["c7833be1-34d9-43e4-8aff-966c14aa2798"], "spl_set_id": ["31362045-201f-45f3-99f2-a5e322a0c30b"], "package_ndc": ["82009-029-05", "82009-030-10", "82009-032-10", "82009-031-30", "82009-031-90"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "97336", "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "address_1": "200 Connell Dr Ste 4200", "address_2": "N/A", "postal_code": "07922-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, AZ, IN", "recall_number": "D-0580-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain.  Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC  82009-032-10", "product_quantity": "1,856 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20250725", "center_classification_date": "20250812", "report_date": "20250820", "code_info": "Lot 240539C, Exp 1/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0633-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-048-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305062, exp 31-08-25; Z306324, Exp Date 30-11-25; Z401151, Z401152, Exp Date 28-02-26"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090355"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-356", "68462-380"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["aaa6684e-4eef-42a8-92b6-8f317e570903"], "spl_set_id": ["56fc2167-ceb6-4e3e-8ff7-5e400dfbd533"], "package_ndc": ["68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05"], "is_original_packager": [true], "upc": ["0368462380017", "0368462356012"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "96867", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0452-2025", "product_description": "Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.  NDC: 68462-356-01", "product_quantity": "8,520 100-count bottles", "reason_for_recall": "OOS results reported for the Dissolution (by UV) test.", "recall_initiation_date": "20250515", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206880"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM INJECTION"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "product_ndc": ["43598-635", "43598-636", "43598-637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["1193358", "1193360", "1193362"], "spl_id": ["f5cfc6e1-79f3-bd25-5f66-9ea05bc47def"], "spl_set_id": ["0a9234b7-46b1-8e6c-a992-90f86cfb6e00"], "package_ndc": ["43598-635-52", "43598-635-10", "43598-636-52", "43598-636-10", "43598-637-52", "43598-637-10"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "96470", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0365-2025", "product_description": "Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-636-52", "product_quantity": "4,010 bags", "reason_for_recall": "LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.", "recall_initiation_date": "20250313", "center_classification_date": "20250416", "report_date": "20250423", "code_info": "Lot: A1540076, Exp 08/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Tempe", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96735", "recalling_firm": "SAINI TRADE INC", "address_1": "1405 N Scottsdale Rd", "address_2": "", "postal_code": "85288-1714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0465-2025", "product_description": "ELECTRO BUZZ, Dietary Supplement, 10 capsules per box, Distributed By: Health Fixer, Tempe, AZ 85288, UPC B0DK68LF6J.", "product_quantity": "300 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.", "recall_initiation_date": "20250414", "center_classification_date": "20250611", "report_date": "20250618", "code_info": "All lots Lot #: KT-1ST-43-01-07/2024, Exp. 10/15/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-068"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM"], "rxcui": ["1188426"], "spl_id": ["435361c6-ed83-3e7b-e063-6394a90ac92f"], "spl_set_id": ["b479d2ae-4b59-916a-e053-2995a90af8ec"], "package_ndc": ["50268-068-15", "50268-068-02"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "96032", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0175-2025", "product_description": "Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by: AvKARE, Pulaski, TN, 38478, NDC 50268-068-15.", "product_quantity": "16,677 cartons", "reason_for_recall": "LABELING: LABEL MIX-UP", "recall_initiation_date": "20241218", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lot #: 0160, Exp. Date April 26 2026", "more_code_info": ""}, {"status": "Completed", "city": "Montgomery", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022363"], "brand_name": ["LIVALO"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["Kowa Pharmaceuticals America, Inc."], "product_ndc": ["66869-104", "66869-204", "66869-404"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861646", "861648", "861650", "861652", "861654"], "spl_id": ["8c680b64-3b3d-486d-b64b-a8645d925bba"], "spl_set_id": ["44dcbf97-99ec-427c-ba50-207e0069d6d2"], "package_ndc": ["66869-104-90", "66869-204-90", "66869-204-07", "66869-404-90", "66869-404-07"], "is_original_packager": [true], "upc": ["0366869404909", "0366869104908"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "96379", "recalling_firm": "Kowa Pharmaceuticals America", "address_1": "530 Industrial Park Blvd", "address_2": "", "postal_code": "36117-5543", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "PA, OH, and TX", "recall_number": "D-0258-2025", "product_description": "Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90  HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case", "product_quantity": "5,328 Bottles", "reason_for_recall": "Presence of foreign tablets/capsules", "recall_initiation_date": "20250224", "center_classification_date": "20250307", "report_date": "20250319", "code_info": "Lot#: 3231300, Exp 8/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0553-2025", "product_description": "Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "290 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-544", "67877-545"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110", "309113"], "spl_id": ["84f07b4a-a15e-41cb-af85-e110c5cf342e"], "spl_set_id": ["bb28751c-bd1b-4e7f-8271-a14c1b4314e3"], "package_ndc": ["67877-544-88", "67877-544-68", "67877-545-88", "67877-545-68"], "is_original_packager": [true], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "96912", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0469-2025", "product_description": "Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascent Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-544-68", "product_quantity": "10,620 - 200 mL bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.    The individual impurity was identified to be Cephalexin Glucose Adduct.", "recall_initiation_date": "20250523", "center_classification_date": "20250612", "report_date": "20250618", "code_info": "Lot #: 23142343, Exp Date: 6/30/2025; 23143526, Exp Date: 9/30/2025; 23144036, Exp Date: 10/31/2025; 23144269, Exp Date: 11/30/2025; Lot 24140027, Exp Date: 12/31/2025; 24144282, Exp Date: 10/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA209959"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-142"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123111"], "spl_id": ["234fba93-8b9b-46de-8d61-088bd0a30b98"], "spl_set_id": ["c4d6d76a-14b8-411a-8019-e2c923c2c532"], "package_ndc": ["69097-142-60"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "97304", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0593-2025", "product_description": "Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.", "product_quantity": "20352 packs (1x 200 MD)", "reason_for_recall": "Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.", "recall_initiation_date": "20250724", "center_classification_date": "20250820", "report_date": "20250827", "code_info": "Lot#: 4IB0519, Exp. 04/30/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205268"], "brand_name": ["PROPAFENONE HYDROCHLORIDE"], "generic_name": ["PROPAFENONE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-408", "68462-409", "68462-410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPAFENONE HYDROCHLORIDE"], "rxcui": ["861156", "861164", "861171"], "spl_id": ["064ec508-4c51-41fa-929f-0abe45b4779b"], "spl_set_id": ["d818af31-2535-4595-82fe-fd7abf66fd6c"], "package_ndc": ["68462-408-60", "68462-409-60", "68462-410-60"], "is_original_packager": [true], "upc": ["0368462409602", "0368462410608", "0368462408605"], "unii": ["33XCH0HOCD"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0316-2025", "product_description": "Propafenone Hydrochloride Extended-Release Capsules 325mg, 60-count bottle, Rx Only Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-409-60", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230767, exp. date Mar-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0448-2025", "product_description": "Carvedilol Tablets USP 3.125mg Tablets  a.)100-count bottle (NDC 68462-162-01), b.) 500-count bottle (NDC 68462-162-05),  Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "[100 Tablet Bottles] 59,952 bottles; [500 Tablet Bottles] 155,976 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "[100-Count Bottles]   Lot 19231450, Exp Mar-25, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lot 19240280, Exp DEC-25  [500-Count Bottles]   Lot 19231450, 19231464, 19231471, 19231493, Exp Mar-25, 19232083, 19232103 Exp Apr-25, 19232658, Exp Jun-25; Lot 19233328, 19233343, 19233344, 19233345, Exp Jul-25; Lot 19234275, Exp Sep-25; Lots 19234843,  19235039, Exp Nov-25; Lots 19240280, 19240296, Dec-25"}, {"status": "Ongoing", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96003", "recalling_firm": "Alcon Research LLC", "address_1": "6201 South Fwy", "address_2": "", "postal_code": "76134-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0200-2025", "product_description": "Systane Lubricant Eye Drops, Ultra PF, Sterile, 25 Vials (0.7mL Each), Manufactured for: Alcon Laboratories, Inc. Forth Worth, TX 76134", "product_quantity": "55,960 25-count boxes", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20241218", "center_classification_date": "20250113", "report_date": "20250122", "code_info": "Lot 10101; Exp.09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95900", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0165-2025", "product_description": "Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA", "product_quantity": "a) 1,564 cards, b) 799 bottles", "reason_for_recall": "CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241202", "center_classification_date": "20241226", "report_date": "20250101", "code_info": "a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97372", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0588-2025", "product_description": "Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India.  Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430 NDC: 68462-165-05", "product_quantity": "14,976 bottles", "reason_for_recall": "CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm", "recall_initiation_date": "20250806", "center_classification_date": "20250814", "report_date": "20250820", "code_info": "Lot #: 17241213, 17241215, 17241224, Exp. Date 06/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA089424"], "brand_name": ["SPIRONOLACTONE"], "generic_name": ["SPIRONOLACTONE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["53489-143", "53489-328", "53489-329"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SPIRONOLACTONE"], "rxcui": ["198222", "198223", "313096"], "spl_id": ["3dbb5369-c3a5-47b8-91e4-5715b22aa7d9"], "spl_set_id": ["c23b6b9b-aec3-48a8-a518-76e4097f6479"], "package_ndc": ["53489-143-01", "53489-143-05", "53489-143-10", "53489-328-07", "53489-328-02", "53489-328-06", "53489-328-01", "53489-328-03", "53489-328-05", "53489-328-10", "53489-329-07", "53489-329-02", "53489-329-06", "53489-329-01", "53489-329-03", "53489-329-05", "53489-329-10"], "is_original_packager": [true], "upc": ["0353489143011", "0353489329019"], "nui": ["N0000175557", "N0000011310"], "pharm_class_epc": ["Aldosterone Antagonist [EPC]"], "pharm_class_moa": ["Aldosterone Antagonists [MoA]"], "unii": ["27O7W4T232"]}, "product_type": "Drugs", "event_id": "97391", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0574-2025", "product_description": "Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01", "product_quantity": "11,328 bottles", "reason_for_recall": "Presence of foreign substance: identified as aluminum.", "recall_initiation_date": "20250805", "center_classification_date": "20250807", "report_date": "20250813", "code_info": "Lot # P3314, Exp 11/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Gilsum", "state": "NH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "96122", "recalling_firm": "The W.S. Badger Company, Inc.", "address_1": "768 Route 10", "address_2": "", "postal_code": "03448-7503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0209-2025", "product_description": "BADGER 50, ADVENTURE SPORT MINERAL SUNSCREEN WITH CLEAR ZINC, (uncoated 25% zinc oxide), 2.4 oz., Tin, W.S. Badger Company, Inc, 768 Route 10, Gilsum NH, 03448 UPC 6 34084 47150 2", "product_quantity": "4,834 tins", "reason_for_recall": "Labeling: Missing Label: The finished product potentially  missing the labeling with the drug facts panel, bar code and directions for use.", "recall_initiation_date": "20250117", "center_classification_date": "20250129", "termination_date": "20250707", "report_date": "20250205", "code_info": "LOT# 091923A, Exp. Date 09/19/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203503"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-572", "68462-573"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["349434", "349435"], "spl_id": ["1c47b796-6b3e-4321-86f6-f51fbf9a39fb"], "spl_set_id": ["4cbac6ad-0faa-4181-a830-27a9f1536b7a"], "package_ndc": ["68462-572-30", "68462-572-90", "68462-572-13", "68462-573-30", "68462-573-90", "68462-573-13"], "is_original_packager": [true], "upc": ["0368462573303"], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0319-2025", "product_description": "Voriconazole Tablets 50mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-572-30.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17231045, exp. date Apr-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203480"], "brand_name": ["COLESEVELAM HYDROCHLORIDE"], "generic_name": ["COLESEVELAM HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-433"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLESEVELAM HYDROCHLORIDE"], "rxcui": ["866910"], "spl_id": ["836cbdcd-e2b0-468f-8aff-32ecd9760e78"], "spl_set_id": ["845b8661-0aa9-418f-a496-df3d7a3130ff"], "package_ndc": ["68462-433-90", "68462-433-18"], "is_original_packager": [true], "upc": ["0368462433188"], "unii": ["P4SG24WI5Q"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0340-2025", "product_description": "Colesvelam Hydrocholoride Tablets 625mg, 180-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-433-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17240669, exp. date Mar-26 17240876, exp. date Apr-26 17240883, exp. date May-26 17240909, exp. date May-26 17240914, exp. date May-26 17240927, exp. date May-26"}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96428", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0291-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-443-20.", "product_quantity": "1,068 cartons", "reason_for_recall": "Super-Potent Drug: Out of specification potency results were obtained.", "recall_initiation_date": "20250307", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "Lot 3115773, Exp. 03/31/2025"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8a5df7d8-ad17-44d7-9c56-44fa2aaa0852"], "spl_set_id": ["fc2bd95d-a7bc-4ab5-bffa-f5059cb8eb63"], "package_ndc": ["70710-1129-1", "70710-1129-2", "70710-1129-4", "70710-1130-1", "70710-1130-2", "70710-1130-4", "70710-1131-1", "70710-1131-2", "70710-1131-4", "70710-1132-1", "70710-1132-2", "70710-1132-4", "70710-1133-1", "70710-1133-2", "70710-1133-4"], "is_original_packager": [true], "upc": ["0370710112912", "0370710113216", "0370710113018"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0632-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle,  Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.  NDC: 70710-1130-1", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z305060, Z305061, Exp Date 31-08-25; Z306323, Exp Date 30-11-25; Z401153, Exp Date 28-02-26; Z403015, Z403016, Exp Date 30-04-26; Z405591, Exp Date 30-09-26"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95930", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0172-2025", "product_description": "Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03.  packaged in an Airless pump pack", "product_quantity": "2760 packs", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241210", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7043", "0904-7044", "0904-7045"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["d893474d-4a41-4771-88d3-25ea749deeff"], "spl_set_id": ["fdc774b5-c8f2-4daf-94cb-7e73548b541a"], "package_ndc": ["0904-7043-04", "0904-7043-61", "0904-7044-61", "0904-7045-61"], "original_packager_product_ndc": ["57237-017", "57237-018", "57237-019"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96105", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0212-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.", "product_quantity": "a) 6408 boxes and b)1488 boxes", "reason_for_recall": "CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit", "recall_initiation_date": "20250113", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-162", "50268-163", "50268-164", "50268-165", "50268-166"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["0e85a5c9-76a9-f621-e063-6394a90a8782"], "spl_set_id": ["9e8cebc0-7fcf-dca8-e053-2a95a90a3369"], "package_ndc": ["50268-162-11", "50268-162-15", "50268-163-11", "50268-163-15", "50268-164-11", "50268-164-15", "50268-165-11", "50268-165-15", "50268-166-11", "50268-166-12"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97548", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0643-2025", "product_description": "chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15", "product_quantity": "1512 cartons", "reason_for_recall": "Presence of a foreign substance.", "recall_initiation_date": "20250825", "center_classification_date": "20250911", "report_date": "20250917", "code_info": "Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205994"], "brand_name": ["SAXAGLIPTIN"], "generic_name": ["SAXAGLIPTIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-726", "68462-727"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SAXAGLIPTIN HYDROCHLORIDE"], "rxcui": ["858036", "858042"], "spl_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "spl_set_id": ["e286ffd4-c598-47fb-af06-2e15f7e6f99f"], "package_ndc": ["68462-726-30", "68462-726-90", "68462-726-05", "68462-727-30", "68462-727-90", "68462-727-05", "68462-727-14"], "is_original_packager": [true], "upc": ["0368462726907"], "unii": ["Z8J84YIX6L"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0332-2025", "product_description": "Saxagliptin Tablets 5mg, a). 30-count bottle (NDC# 68462-727-30) b.) 90-count bottle ( 68462-727-90), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232460, exp. date Nov-25 17232460, exp. date Nov-25 17241194, exp. date Jun-26 17241194, exp. date Jun-26"}, {"status": "Ongoing", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96996", "recalling_firm": "Tailstorm Health INC", "address_1": "24416 N 19th Ave Ste 200", "address_2": "", "postal_code": "85085-1400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0502-2025", "product_description": "LIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,000, For Infiltration & Nerve Block, Including Caudal & Epidural Use, 10 mL Sterile Single-Dose Vial, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene, Rd. Chandler, AZ 85226, NDC 81483-0037-0.", "product_quantity": "2825 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.", "recall_initiation_date": "20250602", "center_classification_date": "20250630", "report_date": "20250709", "code_info": "Lot #s: 2503004, Exp. 3/23/2026; 2503005, Exp. 3/25/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209288"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-511", "67877-512", "67877-513", "67877-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["777b866a-796a-4d15-8cb6-dd0c9a1856e2"], "spl_set_id": ["67e60880-091a-4df7-8696-6e6c42a490e2"], "package_ndc": ["67877-511-90", "67877-511-05", "67877-511-10", "67877-511-55", "67877-511-33", "67877-511-38", "67877-512-90", "67877-512-05", "67877-512-10", "67877-512-44", "67877-512-33", "67877-512-38", "67877-513-90", "67877-513-05", "67877-513-10", "67877-513-23", "67877-513-33", "67877-513-38", "67877-514-90", "67877-514-05", "67877-514-10", "67877-514-33", "67877-514-38"], "is_original_packager": [true], "upc": ["0367877512051", "0367877513102", "0367877514109"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "97639", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0019-2026", "product_description": "Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90),  b). 500-count (NDC 67877-512-05), c). 1000-count(NDC 67877-512-10),Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250919", "center_classification_date": "20251010", "report_date": "20251022", "code_info": "Lot #: 25140150, Exp.  Dec. 2026 Lot #: 25140173, Exp. Dec. 2026 Lot #: 25140172, Exp. Dec. 2026 Lot #: 24144720, Exp. Nov. 2026 Lot #: 24144798, Exp.  Nov. 2026 Lot #: 24144692, Exp. Oct. 2026 Lot #: 24143755, Exp.  Aug. 2026 Lot #: 24143913, Exp. Aug. 2026 Lot #: 24143754, Exp.  Aug. 2026 Lot #: 24143047, Exp. June 2026 Lot #: 24142936, Exp. July 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Kennett Square", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97202", "recalling_firm": "Boothwyn Pharmacy LLC", "address_1": "221 Gale Ln", "address_2": "N/A", "postal_code": "19348", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0607-2025", "product_description": "Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496", "product_quantity": "8 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250709", "center_classification_date": "20250829", "report_date": "20250910", "code_info": "06092025@23 BUD 09/09/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206391"], "brand_name": ["NITROGLYCERIN"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-638", "68462-639", "68462-640"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["198038", "198039", "198040"], "spl_id": ["91f10148-6ba2-41ef-b454-0f22741a77d3"], "spl_set_id": ["fa789d65-9407-4965-bd06-4457444b42be"], "package_ndc": ["68462-638-01", "68462-639-01", "68462-639-25", "68462-639-45", "68462-640-01"], "is_original_packager": [true], "upc": ["0368462638019", "0368462639016", "0368462640012"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0324-2025", "product_description": "Nitroglycerin  Sublingual Tablets 0.4MG 100-count carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-639-45.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232024, exp. date Aug-25 17232071, exp. date Sep-25 17232072, exp. date Sep-25"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0231-2025", "product_description": "Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-265-30.", "product_quantity": "70,032 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232368, Exp:5/2025; 19235088, Exp.: 11/2025; 19241447, Exp.: 3/2026; 19243146, Exp.: 7/2026."}, {"status": "Ongoing", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078177"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807639"], "spl_id": ["26587576-d68d-4c98-e063-6394a90ac53d"], "spl_set_id": ["af5cdf1a-19f4-11e2-892e-0800200c9a66"], "package_ndc": ["49230-300-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "96877", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 920", "address_2": "", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0490-2025", "product_description": "0.9% Sodium Chloride Injection, USP, Flexible Plastic Container, Rx Only Fresenius Medical Care North America, Waltham, MA 02451, 1-800-323-5188, NDC 49230-300-10", "product_quantity": "3,651,468 containers", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250527", "center_classification_date": "20250623", "report_date": "20250702", "code_info": "24PU06037, 24PU06038, 24PU06040, 24PU06041, 24PU06042, 24PU06043, 24PU06044, 24PU06045, 24PU0646, 24PU06047, 24PU06048, 24PU06049, 24PU06050, 24PU06052, 24PU06053, 24PU06054 & 24PU06055, Exp Date 11/30/2025;  24SU06001, 24SU06002, 24SU06003, 24SU06004, 24SU06005, 24SU06006, 24SU06007, 24SU06009, 24SU06010, 24SU06011 24SU06012, 24SU06013, 24SU06014, 24SU06015, 24SU06016, 24SU06017, 24SU06018, 24SU06019, 24SU06020, 24SU06021, 24SU06022, 24SU06023, 24SU06024, 24SU06025,24SU06026, 24SU06028,24SU06029, 24SU06030, 24SU06031, 24SU06032, 24SU06033 24SU06034, 24SU06035, 24SU06036, 24SU06037, 24SU06038, 24SU06039, 24SU06040, 24SU06041, 24SU06042, 24SU06043, 24SU06044, 24SU06045, 24SU06046, 24SU06047, 24SU06048, 24SU06049, 24SU06050, 24SU06051, 24SU06052, 24SU06053, 24SU06054, 24SU06055, 24SU06056, & 24SU06057,  Exp Date 12/31/25   25AU06001, 25AU06002, 25AU06003. 25AU06004, 25AU06005, 25AU06006, 25AU06007, 25AU06008, 25AU06009, 25AU06010, 25AU06011, 25AU06013, 25AU06017, 25AU06020 25AU06021, 25AU06022, 25AU06027, 25AU06028, 25AU06029, 25AU06030, 25AU06031 25AU06032, 25AU06034, 25AU06035, 25AU06036, 25AU06037, 25AU06038, 25AU06039 25AU06040, 25AU06041, 25AU06042, 25AU06043, 25AU06044, 25AU06045, 25AU06046 25AU06047, 25AU06048, 25AU06049, 25AU06050, 25AU06051, 25AU06052, 25AU06053 & 25AU06056, Exp Date 1/31/26  25BU06001, 25BU06003, 25BU06004, 25BU06005, 25BU06006, 25BU06007, 25BU06008 25BU06009, 25BU06010, 25BU06011, 25BU06018, 25BU06020, 25BU06023, 25BU06024 25BU06026, 25BU06027, 25BU06028, 25BU06030, 25BU06031, 25BU06032, 25BU06033 25BU06034, 25BU06035, 25BU06036, 25BU06037, 25BU06038, 25BU06039, 25BU06040 25BU06041, 25BU06042, 25BU06043, 25BU06044, 25BU06045, 25BU06046 25BU06047, 25BU06049, 25BU06050, 25BU06051, 25BU06053 & 25BU06054,  Exp Date 02/28/26  25CU06002, 25CU06003, 25CU06004, 25CU06005, 25CU06006, 25CU06007, 25CU06008 25CU06012, 25CU06013, 25CU06015, 25CU06016, 25CU06020, 25CU06021, 25CU06022 25CU06023, 25CU06024, 25CU06026, 25CU06028, 25CU06030, 25CU06032, 25CU06035 25CU06039, Exp Date 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Elkins Park", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97831", "recalling_firm": "ibspot", "address_1": "1414 Willow Ave", "address_2": "", "postal_code": "19027-3147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "WY and VA", "recall_number": "D-0098-2026", "product_description": "Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N", "product_quantity": "3 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA", "recall_initiation_date": "20251009", "center_classification_date": "20251023", "report_date": "20251029", "code_info": "none", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["ARTIFICIAL TEARS"], "generic_name": ["ARTIFICIAL TEARS"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-043"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXTRAN 70", "GLYCERIN", "HYPROMELLOSES"], "rxcui": ["900138"], "spl_id": ["334b4087-9641-b765-e063-6394a90a28a6"], "spl_set_id": ["f18bebf2-1936-658f-e053-2a95a90a5012"], "package_ndc": ["50268-043-15"], "is_original_packager": [true], "nui": ["N0000184175", "N0000009361", "N0000010288", "N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Plasma Volume Expander [EPC]", "Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Intravascular Volume [PE]", "Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["7SA290YK68", "PDC6A3C0OX", "3NXW29V3WO"]}, "product_type": "Drugs", "event_id": "96741", "recalling_firm": "BRS Analytical Services, LLC", "address_1": "11697 Lakeside Crossing Ct", "address_2": "N/A", "postal_code": "63146-8606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0404-2025", "product_description": "Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants) Lubricant Eye Drops, STERILE, 0.5 FL OZ (15 mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-043-15.", "product_quantity": "13,872 cases (24 cartons per case)", "reason_for_recall": "cGMP deviations and lack of assurance of sterility.", "recall_initiation_date": "20250423", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot, expiry:  Lot 126, exp 10/26/25; Lot 127, exp 10/30/25; Lot 128, exp 11/02/25; Lot 129, exp 11/06/25; Lot 162, exp 5/09/26; Lot 163, exp 5/14/26; Lot 164, exp 5/20/26; Lot 165, exp 5/23/26; Lot 166, exp 5/29/26; Lot 167, exp 6/03/26; Lot 168, exp 6/06/26; Lot 169, exp 6/10/26; Lot 170, exp 6/13/26; Lot 193, exp 10/07/26; Lot 194, exp 10/10/26; Lot 195, exp 10/14/26; Lot 196, exp 10/17/26; Lot 197, exp 10/21/26; Lot 198, exp 10/24/26; Lot 199, exp 10/30/26.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96308", "recalling_firm": "Safecor Health, LLC", "address_1": "4060 Business Park Dr Ste B", "address_2": "", "postal_code": "43204-5047", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0250-2025", "product_description": "Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.", "product_quantity": "3069 Oral Syringes", "reason_for_recall": "Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.", "recall_initiation_date": "20250217", "center_classification_date": "20250305", "report_date": "20250312", "code_info": "Lot #:  24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dabhel, Daman", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97766", "recalling_firm": "USV Private Limited", "address_1": "H-13, 16, 16a, 17, 18, 19, 20, 21 & E-22, Oidc, Mahatma Gandhi Udyog Nagar", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0034-2026", "product_description": "Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05", "product_quantity": "8,952 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.", "recall_initiation_date": "20251009", "center_classification_date": "20251020", "report_date": "20251029", "code_info": "Lot #:  35000409, Exp. Date 01/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-419", "60687-430", "60687-441", "60687-452", "60687-463"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["19336340-ad22-62b7-e063-6294a90affed"], "spl_set_id": ["d43718e5-66d7-44f9-9fc8-80d38d3e41ce"], "package_ndc": ["60687-419-11", "60687-419-01", "60687-430-11", "60687-430-01", "60687-430-65", "60687-441-11", "60687-441-01", "60687-452-11", "60687-452-01", "60687-463-11", "60687-463-01"], "original_packager_product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97533", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0648-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet Carton NDC#: 60687-441-01 (Individual Dose NDC: 60687-441-11)", "product_quantity": "1,062 cartons", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250827", "center_classification_date": "20250915", "report_date": "20250924", "code_info": "Lot: 1022159, exp 12/31/2026; 1023299, exp 03/31/2027; 1024057, Exp 04/30/2027"}, {"status": "Ongoing", "city": "ISELIN", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216436"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Biocon Pharma Inc."], "product_ndc": ["70377-077", "70377-078", "70377-079", "70377-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["72b8b3f5-4658-80af-655c-87ce7966a5e6"], "spl_set_id": ["5b839619-1805-c227-91bf-182f5b966ba4"], "package_ndc": ["70377-077-11", "70377-077-13", "70377-077-12", "70377-078-11", "70377-078-13", "70377-078-12", "70377-079-11", "70377-079-12", "70377-079-13", "70377-080-11", "70377-080-12", "70377-080-13"], "is_original_packager": [true], "upc": ["0370377080111"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "96496", "recalling_firm": "BIOCON PHARMA INC", "address_1": "485 HWY 1 (S)", "address_2": "", "postal_code": "08830", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "U.S.A. nationwide", "recall_number": "D-0306-2025", "product_description": "Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13", "product_quantity": "2184 bottles", "reason_for_recall": "Failed dissolution specifications: lower than specifications", "recall_initiation_date": "20250317", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot#: AVC24035, Exp 03/31/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "96740", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0403-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-01.", "product_quantity": "60428 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250418", "center_classification_date": "20250505", "report_date": "20250514", "code_info": "Lot #: 083I098, Exp. Date 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96290", "recalling_firm": "Ascent Consumer Products Inc.", "address_1": "105 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3833", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0299-2025", "product_description": "SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 Soft tip Squeeze Bottle, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00104 1", "product_quantity": "4,176 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus", "recall_initiation_date": "20250128", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot# 024122661Al, Exp Date 12/2027"}, {"status": "Ongoing", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050708"], "brand_name": ["PROGRAF"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-0607", "0469-0617", "0469-0657", "0469-3016", "0469-1230", "0469-1330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["108513", "108514", "108515", "198377", "198378", "198379", "261134", "313190", "2052605", "2052609", "2052703", "2052704"], "spl_id": ["e9157663-1515-4ba3-83b5-1622cf6f0f99"], "spl_set_id": ["7f667de1-9dfa-4bd6-8ba0-15ee2d78873b"], "package_ndc": ["0469-0607-73", "0469-0617-73", "0469-0617-11", "0469-0657-73", "0469-0657-11", "0469-3016-01", "0469-1230-50", "0469-1330-50"], "is_original_packager": [true], "upc": ["0304690607731", "0304690657736", "0304691230501", "0304691330508", "0304690617730", "0304693016011"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "96008", "recalling_firm": "Astellas Pharma US Inc.", "address_1": "2375 Waterview Dr", "address_2": "", "postal_code": "60062-6145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0211-2025", "product_description": "Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.", "product_quantity": "14,340 100-count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules", "recall_initiation_date": "20241223", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot# 0E3353D, Exp 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA761062"], "brand_name": ["EVENITY"], "generic_name": ["ROMOSOZUMAB-AQQG"], "manufacturer_name": ["Amgen Inc"], "product_ndc": ["55513-880", "55513-998"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["ROMOSOZUMAB"], "rxcui": ["2123184", "2123185", "2123190", "2123191"], "spl_id": ["112895a2-37db-4ca8-afa6-34585bfb685b"], "spl_set_id": ["471baba2-7154-4488-9891-0db2f46791e7"], "package_ndc": ["55513-880-01", "55513-880-02", "55513-998-01", "55513-998-02"], "is_original_packager": [true], "unii": ["3VHF2ZD92J"]}, "product_type": "Drugs", "event_id": "97110", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S - OH, VA, FL.", "recall_number": "D-0539-2025", "product_description": "EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.", "product_quantity": "2 Pre-filled syringes", "reason_for_recall": "CGMP Deviations; potential temperature excursions due to transit delays", "recall_initiation_date": "20250421", "center_classification_date": "20250721", "report_date": "20250730", "code_info": "Lot: 1178382, Expiration date: 3/31/2027"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203016"], "brand_name": ["TOLTERODINE TARTRATE"], "generic_name": ["TOLTERODINE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6593", "0904-6592"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOLTERODINE TARTRATE"], "rxcui": ["855182", "855189"], "spl_id": ["29bf12b7-e530-4337-a021-ca7138b39d78"], "spl_set_id": ["da9423b5-00ab-46fc-8959-3db3c0a0bc6d"], "package_ndc": ["0904-6592-04", "0904-6593-04"], "original_packager_product_ndc": ["13668-189", "13668-190"], "unii": ["5T619TQR3R"]}, "product_type": "Drugs", "event_id": "96416", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0304-2025", "product_description": "Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.", "product_quantity": "224 cartons", "reason_for_recall": "Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.", "recall_initiation_date": "20250304", "center_classification_date": "20250328", "report_date": "20250409", "code_info": "Lot# T05393, Exp. Date: 09/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7129", "0904-7130", "0904-7131", "0904-7132", "0904-7133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["be5824c1-1eca-44db-a689-c67b9808c1f9"], "spl_set_id": ["d58570a0-58b0-4662-b2ad-aa8d1463b4c1"], "package_ndc": ["0904-7129-61", "0904-7130-61", "0904-7130-06", "0904-7131-61", "0904-7132-61", "0904-7133-61", "0030904713"], "original_packager_product_ndc": ["70710-1129", "70710-1130", "70710-1131", "70710-1132", "70710-1133"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97584", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0013-2026", "product_description": "Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7133-61, UPC (01)00309047133611  NDC 0904-7133-61", "product_quantity": "1394 blister packs", "reason_for_recall": "CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit", "recall_initiation_date": "20250912", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lots N01928, Exp. Date, 09/30/2025, N02008, Exp. Date, 03/21/2026 & N02071, Exp. Date 02/28/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96232", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in PA", "recall_number": "D-0225-2025", "product_description": "fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CII, Single use  100mL IV Bag, Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67726 Bar Code 71266-5060-01", "product_quantity": "1330 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250131", "center_classification_date": "20250219", "report_date": "20250226", "code_info": "Lot # C274-000040409, Exp 03/22/2025"}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["ZAPZYT ACNE TREATMENT GEL"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Focus Consumer Healthcare, LLC"], "product_ndc": ["71687-0011"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["486131"], "spl_id": ["2df18af1-0ee0-39d1-e063-6394a90ae62a"], "spl_set_id": ["6079d45c-dd86-6f2e-e053-2991aa0a9743"], "package_ndc": ["71687-0011-1"], "is_original_packager": [true], "upc": ["0010768001102"], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "96384", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0273-2025", "product_description": "Zapzyt, Acne Treatment Gel, 10% benzoyl peroxide Gel, packaged in 1 oz (28.35g) tube, Distributed by: FOCUS CONSUMER HEALTHCARE, LLC., 801 Broad St Ste 200, Chattanooga, TN 37402. NDC 71687-0011-1", "product_quantity": "642,131 tubes", "reason_for_recall": "Chemical Contamination: Presence of benzene.", "recall_initiation_date": "20250224", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "Lot #: 9762, Exp. Date 2/28/2025; 9763, 9764, 9765, Exp. Date 3/31/2025; 9869, 9870, Exp. Date 5/31/2025; 9871, 9872, Exp. Date 7/31/2025; 9996, 9997, 9998, Exp. Date 8/31/2025;  9995, Exp. Date 10/31/2025; 0154, 0153, 0326, Exp. Date 1/31/2026; 0155, 0156, 0161,  0327, 0329, 0328, Exp. Date 2/28/2026; 0479, 0480, Exp. Date 5/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97086", "recalling_firm": "Qualgen, LLC", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0517-2025", "product_description": "Testosterone 200 mg Pellet packaged in 1mL amber vials, Rx only, Compounded product. Qualgen 14844 Bristol Park Blvd Edmond OK 73013, NDC 69761-202-01", "product_quantity": "2,832 amber vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.", "recall_initiation_date": "20250616", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot number: 1043, Exp. Date 2/10/2026"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["5f5b2d20-cc2a-4e91-b2b9-260e7438ab2c"], "spl_set_id": ["c4a21f67-7812-4634-beba-f8e85c63c5f2"], "package_ndc": ["68462-162-60", "68462-162-01", "68462-162-18", "68462-162-05", "68462-162-10", "68462-163-60", "68462-163-01", "68462-163-18", "68462-163-05", "68462-163-10", "68462-164-60", "68462-164-01", "68462-164-18", "68462-164-05", "68462-164-10", "68462-165-60", "68462-165-01", "68462-165-18", "68462-165-05", "68462-165-10"], "is_original_packager": [true], "upc": ["0368462162019", "0368462163016", "0368462164013", "0368462165010"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "96861", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0449-2025", "product_description": "Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "[100 Tablet Bottles] 90,000 bottles; [500 Tablet Bottles] 324,288 bottles", "reason_for_recall": "CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit", "recall_initiation_date": "20250228", "center_classification_date": "20250528", "report_date": "20250604", "code_info": "[100-Count Bottles]    Lot 19231618, exp Mar-25; 19232064, exp Apr-25; 19232324, May-25; 19233369, Exp Jul-25;  Lot 19234162, Exp Sep-25; Lot 19240543, Exp Jan-26   [500-Count Bottles]   Lots 19231174, 19231199, 19231164, Exp Feb-25, 19231517,19231527, 19231566,19231568,19231595, 19231618,19231634,19231638, 19231448, Exp Mar-25, 19232043,19232051,19232064, Apr-25, 19232322, 19232324, 19232365, 19232380, 19232389, Exp May-25; Lots 19232736, 19232743, 19232746, 19232756, 19232757, Exp Jun-25; Lots 19233369, 19233371, 19233405, 19233416, Exp Jul-25; Lots 19234162, 19234183, 19234192, 19234204, 19234223, 19234243, 19234263, 19234165, 19234242, Exp Sep-25; Lots 19234743, 19234774, 19234993, Exp Nov-25; Lots 19240223, 19240203, 19240211, 19240214, 19240247, 19240249, 19240272, 19240319, Exp Dec-25; Lot 19240543, Exp Jan-26"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA065079"], "brand_name": ["PENICILLIN G POTASSIUM"], "generic_name": ["PENICILLIN G POTASSIUM"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-6135", "0781-6136"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["PENICILLIN G POTASSIUM"], "rxcui": ["863538"], "spl_id": ["e76e56d8-13b5-4520-8aa3-9202ceef1a03"], "spl_set_id": ["91950983-4884-40d1-abd8-bcc953d61b7f"], "package_ndc": ["0781-6135-94", "0781-6135-95", "0781-6136-94"], "is_original_packager": [true], "unii": ["VL775ZTH4C"]}, "product_type": "Drugs", "event_id": "97140", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0570-2025", "product_description": "Buffered Penicillin G Potassium for Injection, USP 20,000,000 Units (20 million units), For IV use, Sterile, Rx Only, Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781-6136-94.", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million Unit", "recall_initiation_date": "20250627", "center_classification_date": "20250806", "report_date": "20250709", "code_info": "Lot # PG4360, PG4362, Exp. 11/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA216605"], "brand_name": ["ROPIVACAINE HYDROCHLORIDE"], "generic_name": ["ROPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["70121-1732", "70121-1733", "70121-1734", "70121-1735"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "substance_name": ["ROPIVACAINE HYDROCHLORIDE"], "rxcui": ["1734347", "1734355", "1734479", "1734481"], "spl_id": ["aa7176ac-f262-4470-a4de-60e288c05ac3"], "spl_set_id": ["da1ce22b-6a8e-40a2-afbb-011fa3ed3a8b"], "package_ndc": ["70121-1732-9", "70121-1732-3", "70121-1733-9", "70121-1733-3", "70121-1734-7", "70121-1734-3", "70121-1735-7", "70121-1735-3", "70121-1734-1"], "is_original_packager": [true], "upc": ["0370121173533", "0370121173434", "0370121173335", "0370121173311", "0370121173410", "0370121173519", "0370121173397", "0370121173298", "0370121173212"], "unii": ["V910P86109"]}, "product_type": "Drugs", "event_id": "96648", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0402-2025", "product_description": "Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India,  , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)", "product_quantity": "62 (12x100mL) bags", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250417", "center_classification_date": "20250505", "report_date": "20250514", "code_info": "Lot #'s: AL240003, AL240004, Exp.: 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0478-2025", "product_description": "Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "16 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #: O-O8A01-25, Exp 3/7/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209755"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1054", "69238-1056", "69238-1058", "69238-1060", "69238-1062"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2"], "spl_set_id": ["aa086a21-de85-4b03-af58-49b70acf8cf0"], "package_ndc": ["69238-1054-1", "69238-1056-1", "69238-1058-1", "69238-1060-1", "69238-1062-1"], "is_original_packager": [true], "upc": ["0369238105612", "0369238106213"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97438", "recalling_firm": "Amneal Pharmaceuticals, LLC", "address_1": "400 Crossing Blvd Fl 3", "address_2": "N/A", "postal_code": "08807-2863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0619-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100-count bottles Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 69238-1062-1.", "product_quantity": "3,363 100-count bottles", "reason_for_recall": "Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was   detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250818", "center_classification_date": "20250904", "report_date": "20250910", "code_info": "Lot: AM240336, AM240337, Exp Date 02/28/2027."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA218311"], "brand_name": ["ACETAMINOPHEN, IBUPROFEN"], "generic_name": ["ACETAMINOPHEN, IBUPROFEN"], "manufacturer_name": ["GLENMARK THERAPEUTICS INC., USA"], "product_ndc": ["72657-157"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "IBUPROFEN"], "rxcui": ["2387532"], "spl_id": ["80b301bb-8889-4fef-8523-afcb94c0f5fd"], "spl_set_id": ["57a8dc2b-a3bc-49fa-b605-2330155bdbff"], "package_ndc": ["72657-157-18", "72657-157-36", "72657-157-72", "72657-157-74", "72657-157-76", "72657-157-20", "72657-157-05"], "is_original_packager": [true], "upc": ["0372657157742"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["362O9ITL9D", "WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0347-2025", "product_description": "Acetaminophen and Ibuprofen (NSAID) Tablets, 250 mg/125 mg a). 144-count packets (NDC# 72657-157-74), b). 216-count packets( 72657-157-76),Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Product of India", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241302, exp. date Jul-26 Amazon & Walmart 17241140, exp. date Jul-26 Amazon & Walmart 17241141, exp. date Jul-26 Amazon & Walmart"}]